BC
BriaCell Therapeutics Corp.
BCTX · NASDAQ
$4.15 -0.24% (-$0.01)
1M +21.68%
Market Cap $36.7M
P/E Ratio -
Div. Yield -
ROE 165.94%
Bulios Fair Price
$3.76
9.4% downside
Current Price
$4.15
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BCTX is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
99 /100
Cheap P/B 1.53x
P/E N/A
P/FFO N/A
Growth
100 /100
Growing Book val. growth 22.89%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 164.58%
Asset turnover 0.00x
ROE 165.94%
Debt
69 /100
Low Debt/Equity 0.00x
Int. coverage -1,290.21x
Current ratio 7.07x
Stability
22 /100
Unstable Beta 1.52x
Profitable years 0
EPS volatility 61.95%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BCTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
William V. Williams
Employees
16
Headquarters
West Vancouver